NCT00032396

Brief Summary

A study evaluating Retisert in patients with age-related macular degeneration

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2001

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 20, 2002

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 22, 2002

Completed
Last Updated

May 29, 2006

Status Verified

December 1, 2002

First QC Date

March 20, 2002

Last Update Submit

May 25, 2006

Conditions

Keywords

AMDARMDAge-Related Macular DegenerationSubfoveal Choroidal NeovascularizationCNV

Interventions

Sponsors & Collaborators

Study Sites (1)

Control Delivery Systems, Inc.

Watertown, Massachusetts, 02472, United States

Location

MeSH Terms

Conditions

Macular Degeneration

Interventions

Fluocinolone Acetonide

Condition Hierarchy (Ancestors)

Retinal DegenerationRetinal DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

PregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Design

Study Type
interventional
Phase
phase 2
Purpose
TREATMENT
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

March 20, 2002

First Posted

March 22, 2002

Study Start

November 1, 2001

Last Updated

May 29, 2006

Record last verified: 2002-12

Locations